Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Giovanna Luchena"'
Autor:
Giordano, Matteo Conti, Elena Bolzacchini, Giovanna Luchena, Lorenza Bertu’, Paola Tagliabue, Stefania Aglione, Antonio Ardizzoia, Jessica Arnoffi, Francesco Maria Guida, Alessandro Bertolini, Alessandro Pastorini, Maria Duro, Donato Bettega, Giovambattista Roda’, Salvatore Artale, Alessandro Squizzato, Monica
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3465
Trifluridine/tipiracil (TAS-102) is an oral chemotherapy approved for the treatment of metastatic colorectal cancer. The efficacy and tolerability of TAS-102 were shown in phase II-III clinical trials and in several real-life studies. The elderly and
Autor:
M. Reni, E. Giommoni, F. Bergamo, M. Milella, L. Cavanna, M.C. Di Marco, M. Spada, S. Cordio, G. Aprile, G.G. Cardellino, E. Maiello, I. Bernardini, M. Ghidini, S. Bozzarelli, M. Macchini, G. Orsi, I. De Simone, Er. Rulli, L. Porcu, V. Torri, C. Pinto, Michele Reni, Marina Macchini, Giulia Orsi, Umberto Peretti, Mariamaddalena Valente, Elisa Giommoni, Lorenzo Antonuzzo, Francesco Di Costanzo, Francesca Bergamo, Vittorina Zagonel, Sara Lonardi, Federica Buggin, Michele Milella, Silvia Palmerio, Luigi Cavanna, Camilla Di Nunzio, Maria Cristina Di Marco, Elisa Grassi, Massimiliano Spada, Marco Messina, Stefano Cordio, Francesco Avola, Giuseppe Aprile, Salvatore Pagano, Francesca Simionato, Giovanni Gerardo Cardellino, Federica Majer, Evaristo Maiello, Tiziana Pia Latiano, Cinzia Chiarazzo, Fabrizio Artioli, Giorgia Razzini, Antonella Pasqualini, Michele Ghidini, Elisa Binda, Silvia Lazzarelli, Silvia Bozzarelli, Simona Sala, Gabriele Luppi, Elisa Pettorelli, Andrea Spallanzani, Giovanni Vicario, Flavia Salmaso, Marco Basso, Nicola Silvestris, Sabina Del Curatolo, Fable Zustovich, Francesca Bongiovanni, Ciro Longobardi, Ilenia Sandi, Caterina Fontanella, Silvia Montelatici, Monica Giordano, Giovanna Luchena, Micol Gilardoni, Emiliano Tamburini, Britt Rudnas, Barbara Venturini, Barbara Merelli, Giorgia Negrini, Elio Maria Vici, Alessandra Marabese, Cristina Garetto, Paola Curcio, Saverio Cinieri, Margherita Cinefra, Pasqualinda Ferrara, Maurizio Cantore, Patrizia Morselli, Guglielmo Fumi, Agnese Isidori, Giovanni Ciccarese, Giovanni Luca Paolo Frassineti, Flavia Pagan, Vanja Vaccaro, Chiara Spoto, Marianna Ferrara, Carlo Garufi, Marta Caporale, Enrico Vasile, Francesca Salani, Elisa Barone, Rossana Berardi, Azzurra Onofri, Zelmira Ballatore, Alessandra Lucarelli, Alessandra Barucca, Amedeo Pancotti, Teresa Scipioni, Katia Bencardino, Giovanna Marrapese, Laura Idotta, Fausto Petrelli, Veronica Lonati, Anna Ceribelli, Angelo Giuli, Cristina Zannori, Maria Bassanelli, Andrea Mambrini, Laura Ginocchi, Massimo Orlandi, Luigi Celio, Monica Niger, Lavinia Biamonte, Stefano Tamberi, Alessandra Piancastelli, Giorgio Papiani, Irene Valli, Paolo Allione, Maria Giovanna Boe, Mario Scartozzi, Eleonora Lai, Annagrazia Pireddu, Pina Ziranu, Laura Demurtas, Marco Puzzoni, Stefano Mariani, Andrea Pretta, Nicole Liscia, Clementina Savastano, Valentina Malaspina, Giuseppe Tonini, Teresa Grassani, Barbara Barco, Tagliaferri Pierosandro, Domenico Ciliberto, Antonella Ierardi, Natale Daniele Calandruccio, Vincenzo Minotti, Roberta Matocci, Valter Torri, Luca Porcu, Erica Rulli, Irene De Simone, Luciano Carlucci, Eliana Rulli, Davide Poli, Paola Tonto, Francesca Scellato, Carmine Pinto
Background: Information about the adherence to scientific societies guidelines in the ‘real-world’ therapeutic management of oncological patients are lacking. This multicenter, prospective survey was aimed to improve the knowledge relative to 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f827f8705c922ff764aa383826811530
https://hdl.handle.net/11585/919206
https://hdl.handle.net/11585/919206
Autor:
Gerardo Rosati, Chiara Alessandra Cella, Luigi Cavanna, Carla Codecà, Michele Prisciandaro, Stefania Mosconi, Giovanna Luchena, Nicola Silvestris, Ilaria Bernardini, Rossana Casaretti, Federica Zoratto, Domenico Amoroso, Andrea Ciarlo, Sandro Barni, Stefano Cascinu, Cristina Davite, Alessandro Di Sanzo, Alessia Casolaro, Domenico Bilancia, Roberto Labianca
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 25(4)
EOX (epirubicin, oxaliplatin, and capecitabine) is one of the standard regimens for metastatic or locally advanced gastric cancer (GC). A new combination based on fractional docetaxel (low-TOX) has been developed in an attempt to increase the efficac
Autor:
Nicla La Verde, Massimo Di Maio, Laura Palmeri, Irene Rampinelli, Giovanna Luchena, Serena Di Cosimo, Francesco Agustoni, Marco Danova, Daniele Generali, Federica D'Antonio, Angelo Olgiati, Antonio Bernardo, Elena Verri, Angioletta Lasagna, Mariangela Manzoni, Alberto Zaniboni, Benedetta Montagna, Gabriella Farina, Alessandra Raimondi, Franco Nolè, Giovanna Catania, Barbara Tagliaferri, Fabiola Giudici, Guido Poggi, Karen Borgonovo, Ottavia Bernocchi, Monica Giordano, Filippo Pietrantonio, Giordano D. Beretta, Andrea Luciani, Emanuela Balletti, Francesco Grossi, Paolo Andrea Zucali
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1324, p 1324 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1324, p 1324 (2021)
Volume 13
Issue 6
Cancer patients may be at high risk of infection and poor outcomes related to SARS-CoV-2. Analyzing their prognosis, examining the effects of baseline characteristics and systemic anti-cancer active therapy (SACT) are critical to their management thr
Publikováno v:
Clinical colorectal cancer. 18(4)
Autor:
Giovanni Apolone, A. Zaniboni, Gianfranco Pavia, R. Labianca, Bruno Andreoni, N. Pinna, Frank E. Johnson, Eva Negri, Gianfranco Pancera, Gerardo Rosati, Sandro Barni, Pietro Sozzi, Roldano Fossati, Valter Torri, G. Solina, Paola Mosconi, G. Ambrosini, F. Gaion, G. Corradini, G. Martignoni, Giovanna Luchena, Sandro Pignata, Bruno Daniele, Marta Monteforte, M. Duro, Giovanni Oliverio
Publikováno v:
Annals of Oncology. 27:274-280
Background Colorectal cancer is the third most common and the third most lethal cancer in both men and women in developed countries. About 75% of cases are first diagnosed when the disease is classified as localized or regional, undergo potentially c
Autor:
Antonella Galiano, Stefania Schiavon, Massimo Luzzani, Monia Dall'Agata, Vittorina Zagonel, Irene Guglieri, Camilla Di Nunzio, Alfina Bramanti, Alberto Farolfi, Barbara Bocci, Maria Teresa Cattaneo, Andrea Casadei Gardini, Davide Dalu, Angela Ragazzini, Pietro Sozzi, Monica Bosco, Alice Giacobino, Luigi Cavanna, C. Gandini, Cataldo Mastromauro, F. Negri, Carla Codecà, Cristina Pittureri, Silvia Ruscelli, Oriana Nanni, Cristina Autelitano, Marco Maltoni, Luisa Fioretto, Augusto Caraceni, Sonia Zoccali, Giovanni Luca Frassineti, Emanuela Scarpi, Claudia Biasini, Giovanna Luchena, Ferdinando Garetto, Carla Longhi, Alberto Gozza, Luigi Montanari, Silvia Quadrini, Roberto Bortolussi, Monica Giordano, Chiara Broglia, Paolo Pedrazzoli, Angela Buonadonna, Alessandro Comandone, Sara Pini, Marina Faedi, Sara Alquati, Rodolfo Scognamiglio, Teresa Gamucci, Sara Lonardi, Elena Amaducci, Manlio Monti, Elisabetta Sansoni, Daris Ferrari, Maria Simona Pino, Francesca Bergamo, Daniela Degiovanni, Martina Valgiusti
Publikováno v:
European journal of cancer (Oxford, England : 1990). 72
The publisher regrets that the collaborators for this paper were not listed as such within the author details of the published paper. The collaborators were published in the Acknowledgements and are as follows: Alberto Farolfi, Silvia Ruscelli, Marti
Autor:
Andrea Casadei Gardini, Francesca Bergamo, Sonia Zoccali, Teresa Gamucci, Manlio Monti, C. Gandini, Carla Longhi, Angela Buonadonna, Carla Codecà, Paolo Pedrazzoli, Monica Bosco, Oriana Nanni, Cristina Autelitano, Daniela Degiovanni, Augusto Caraceni, Ferdinando Garetto, Alfina Bramanti, Stefania Schiavon, Monica Giordano, Chiara Broglia, Elena Amaducci, Elisabetta Sansoni, Marina Faedi, Daris Ferrari, F. Negri, Emanuela Scarpi, Camilla Di Nunzio, Roberto Bortolussi, Rodolfo Scognamiglio, Angela Ragazzini, Giovanni Luca Frassineti, Davide Dalu, Martina Valgiusti, Antonella Galiano, Sara Pini, Alessandro Comandone, Irene Guglieri, Maria Simona Pino, Sara Alquati, Giovanna Luchena, Alice Giacobino, Claudia Biasini, Barbara Bocci, Maria Teresa Cattaneo, Alberto Farolfi, Pietro Sozzi, Luigi Cavanna, Silvia Quadrini, Sara Lonardi, Alberto Gozza, Luigi Montanari, Cristina Pittureri, Marco Maltoni, Luisa Fioretto, Silvia Ruscelli, Massimo Luzzani, Monia Dall'Agata, Vittorina Zagonel, Cataldo Mastromauro
Aim Early palliative care (EPC) in oncology has shown sparse evidence of a positive impact on patient outcomes, quality of care outcomesand costs. Patients and methods Data for this secondary analysis were taken from a trial of 207 outpatients with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54fd3f3755ccf9176dfda6fae47922d8
http://hdl.handle.net/11585/868732
http://hdl.handle.net/11585/868732
Autor:
F. Negri, Emanuela Scarpi, Giovanna Luchena, Sara Alquati, Alessandro Comandone, Silvia Quadrini, Maria Simona Pino, Angela Buonadonna, Maria Grazia Rodriquenz, Ferdinando Garetto, Monica Giordano, Rodolfo Scognamiglio, Giovanni Luca Frassineti, Marina Faedi, Paolo Pedrazzoli, Roberta Gauna, Silvia Ruscelli, Massimo Costantini, Chiara Broglia, Filomena Narducci, Antonella Galiano, Sonia Zoccali, Chiara Cifatte, Daniela Degiovanni, Massimo Luzzani, Monia Dall'Agata, Alberto Farolfi, Raffaella Bertè, Vittorina Zagonel, Dino Amadori, Elena Amaducci, Elisabetta Sansoni, Pietro Sozzi, Maria Teresa Cattaneo, Daris Ferrari, Andrea Casadei Gardini, Francesca Crepaldi, Martina Valgiusti, Roberto Bortolussi, Cristina Pittureri, Rosa Porzio, Cataldo Mastromauro, Alfina Bramanti, Angela Ragazzini, Marco Maltoni, Luigi Montanari, Leonardo Trentin, Carla Codecà, Augusto Caraceni, Gino Crivellari, Oriana Nanni, Davide Dalu, Sara Pini, Claudia Biasini
Background Early palliative care (EPC) in oncology has been shown to have a positive impact on clinical outcome, quality-of-care outcomes, and costs. However, the optimal way for activating EPC has yet to be defined. Methods This prospective, multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5e1743b024c059e6adb4e4e1589439
http://www.journals.elsevier.com/european-journal-of-cancer/
http://www.journals.elsevier.com/european-journal-of-cancer/
Autor:
Marco Danova, Silvia Brugnatelli, Donatella Grasso, Carmine Tinelli, Giovanna Luchena, P. Pugliese, Raffaella Bertè, Alberto Riccardi, Giovanni Trotti, Giovanni Pansini, Monica Giordano
Publikováno v:
Tumori Journal. 92:6-12
Aims and Background Sequential docetaxel and gemcitabine following initial docetaxel plus epirubicin or vinorelbine association could be worthwhile as first-line treatment of metastatic breast cancer. Methods Fifty-eight patients entered a phase II s